Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Eucrates Biomedical Acquisition Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/08/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
04/26/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
04/13/2023 10-K Annual Report for the period ended December 31, 2022
04/03/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
03/29/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 SC 13G BlackRock Inc. reports a 0% stake in Eucrates Biomedical Acquisition Corp
11/08/2022 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
10/24/2022 8-K Quarterly results
10/12/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/05/2022 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
09/28/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/23/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/16/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
03/31/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/14/2022 SC 13G PRICE T ROWE ASSOCIATES INC reports a 5.4% stake in Eucrates Biomedical Acquisition Corp.
02/08/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "PROMISSORY NOTE Principal Amount: Up to $600,000 Dated as of January 20, 2022 New York, New York Eucrates Biomedical Acquisition Corp., a British Virgin Islands company , promises to pay to the order of Eucrates LLC or its registered assigns or successors in interest , or order, the principal sum of up to Six Hundred Thousand Dollars in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Company to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note. 1.     Principal. The principal balance of this Note shall be payable by the Com..."
12/20/2021 10-K/A Annual Report for the period ended December 31, 2020 [amend]
11/22/2021 10-Q Quarterly Report for the period ended September 30, 2021
11/19/2021 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review &nbsp...
08/16/2021 10-Q Quarterly Report for the period ended June 30, 2021
07/16/2021 10-Q Quarterly Report for the period ended March 31, 2021
07/15/2021 10-K/A Annual Report for the period ended December 31, 2020 [amend]
06/21/2021 8-K Quarterly results
06/01/2021 8-K Quarterly results
05/17/2021 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
03/31/2021 10-K Annual Report for the period ended December 31, 2020
02/12/2021 SC 13G Eucrates LLC reports a 19.5% stake in Eucrates Biomedical Acquisition Corp.
02/05/2021 SC 13G BlackRock Inc. reports a 6.9% stake in EUCRATES BIOMEDICAL ACQUISITION CORP
12/14/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Press Release"
12/07/2020 10-Q Quarterly Report for the period ended September 30, 2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy